ArticleInfluenza and other respiratory viruses2026
Strain Agnostic Influenza Virus Propagation in a Serum-Free, Suspension-Adapted MDCK Cell Line.
Article in Influenza and other respiratory viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe continuing circulation and evolution of seasonal influenza viruses remains a public health and socioeconomic threat on a global scale. Viral surveillance and vaccination of the public have been relied upon to confer and boost immunity in the population. Traditionally, influenza strains are propagated in embryonated chicken eggs, but this process remains imperfect and subject to genetic drift of the virus and a reliable source of eggs. Cell culture-based propagation of influenza virus has recently been commercialized, but this method has been difficult to adapt to lab settings.
methodsMadin-Darby canine kidney (MDCK) cells were adapted to thrive in serum-free growth in suspension. The suspension MDCK (sMDCK) line was characterized by measuring replication and viability during routine passage and infection. Fifteen different influenza strains were propagated using this model and were assayed to determine hemagglutination and plaque forming units and compared to influenza strains grown in adherent cell culture. Microneutralization tests were also conducted to ensure each strain maintained the proper antigenicity.
resultsThe cell line was successfully adapted to serum-free growth in suspension. For each virus strain, the sMDCK platform successfully produced a virus stock in 1-3 days. Additionally, sMDCK progeny virus maintained its antigenicity based on neutralization assays.
conclusionsThis simple, scalable method was used to reliably propagate 15 influenza strains with the elimination of costly reagents and animal serum. The results are comparable to traditional methods, and the protocol presented in this work could be adapted to nearly any laboratory setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.